Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

B. Lowenberg, P. Muus, G.J. Ossenkoppele, P. Rousselot, J.Y. Cahn, N. Ifrah, G. Martinelli, S. Amadori, E. Berman, P. Sonneveld, M. Jongen-Lavrencic, S. Rigaudeau, P. Stockman, A. Goudie, S. Faderl, E. Jabbour, H. Kantarjian

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)6030-6036
JournalBlood
Volume118
Issue number23
DOIs
Publication statusPublished - 2011

Cite this